期刊文献+

钙黏附素和β-连接素与宫颈上皮内瘤变进展的关系

Expression and the Significance of E-cadherin and β-catenin in Cervical Intraepithelial Neoplasia
原文传递
导出
摘要 目的:观察钙黏附素(E-cadherin)和β-连接素(β-catenin)在不同级别宫颈上皮内瘤变组织中的表达,探讨其与宫颈上皮内瘤变进展的关系。方法:采用免疫组化法检测51例宫颈组织病理存档石蜡包埋组织钙黏附素(E-cadherin)和β-连接素(β-catenin)的表达,阳性信号采用图像分析仪进行定量分析。结果:E-cadherin在柱状上皮移位组及CIN I组、CIN II组、CIN III组中的平均光密度值(AOD)分别为:0.0866±0.0392、0.073±0.0122、0.0467±0.0056、0.0396±0.0097;β-catenin在柱状上皮移位组及CIN I组、CIN II组、CIN III组中的平均光密度值(AOD)分别为:0.1101±0.0116、0.1016±0.0108、0.0711±0.0062、0.0515±0.0091。随着CIN病变的升级,钙黏附素和β-连接素的表达均呈下降趋势,二者的平均光密度值(AOD)正相关(r=2.546,P=0.018<0.05)。结论:钙黏附素、β-连接素与宫颈上皮内瘤变的进展相关,在估计CIN的预后中有一定意义。 Objective: To investigate the expression and the significance of E-cadherin and β -catenin in cervical intraepithelial neoplasia. To analysis whether a relationship between expression of E-cadherin and β -catenin and progression of cervical intraepithelial neoplasia. Methods: E-cadherin and β -catenin expressions in 51 cases of CIN and columnar ectopy was detected by Immunohistochemistry method and automatic image analysis technique. Results: The AOD values of E-cadherin in the columnar ectopy group,CIN I group, CIN II group and CIN III group are separately: 0.0866± 0.0392,0.073± 0.0122,0.0467± 0.0056,0.0396± 0.0097. The AOD values of 13 -catenin in the columnar ectopy group,CIN I group,ClN II group and CIN III group are separately: 0.1101 ± 0.0116,0.1016± 0.0108, 0.0711± 0.0062,0.0515± 0.0091.The expressions of E-cadherin and β -catenin in cervical intraepithelial neoplasias are positive correlation notablely (r-2.546,P〈0.05). Conclusions: The results indicate that decreased E-cadherin and β -catenin expression might be related to the progression of cervical intraepithelial neoplasia, the two indicator might be a useful tool to evaluate the prognosis of CIN.
出处 《现代生物医学进展》 CAS 2011年第18期3491-3493,共3页 Progress in Modern Biomedicine
关键词 钙黏附素 Β-连接素 宫颈上皮内瘤变 宫颈肿瘤 免疫组化 E-cadherin β -catenin Cervical Intraepithelial Neoplasm Cervical Carcinoma Immunohistochemistry
  • 相关文献

参考文献8

二级参考文献53

  • 1吴爱如.宫颈癌的早期诊断[J].中国肿瘤,1994,3(3):11-12. 被引量:8
  • 2郑莹,彭芝兰.HPV感染的诊断及其临床意义[J].中国实用妇科与产科杂志,2006,22(10):785-787. 被引量:11
  • 3苏采峰,鲍彦平,邱丽芝.肉眼观察在农村宫颈癌筛查中的应用[J].实用医技杂志,2007,14(5):636-637. 被引量:7
  • 4李琴艳,杨庆忠,付雯.TCT与巴氏细胞学在宫颈癌筛查中的对比研究[J].中国妇幼保健,2007,22(9):1173-1174. 被引量:29
  • 5Bosch FX, Castellsague X, De SS. HPV and cancer:screening or Vaccination?[J]. Br J Cancer, 2008, 98:15-21.
  • 6Parkin DM. Global cancer statistics in the year 2000[J]. Lancet Oncol, 2001, 2(9): 533-543.
  • 7Jin F, Devesa SS, Chow WH, et al. Cancer incidence trends in urban Shanghai, 1972-1994 [J]. Int J Cancer, 1999, 83(4): 435-440.
  • 8Marra F, Cloutier K, Oteng B, et al. Effectiveness and cost effectiveness of human papillomavirus vaccine [J]. Pharmacoeconomics, 2009, 27(2):127-147.
  • 9Warren JB, Gullett H, King V J, et al. Cervical cancer screening and updated Pap guidelines[J]. Prim Care,2009, 36(1): 131-149.
  • 10Gonzalez Sanchez JL, Perez Guerrero C, Celorio Aguilera G, et al. Cytologic correlation between the Bethesda system and colposcopic biopsy [J]. Ginecol Obstet Mex, 1998, 66(7):330.

共引文献242

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部